Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11124573 Compositions and methods related to engineered Fc constructs

Patent 11124573 was granted and assigned to Janssen Biotech on September, 2021 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Momenta Pharmaceuticals

Current Assignee

Janssen Biotech

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

11124573

Patent Inventor Names

Leona E. Ling0

Carlos J. Bosques0

Daniel Ortiz0

James Meador, III0

James S. Huston0

Jonathan C. Lansing0

Laura Rutitzky0

Date of Patent

September 21, 2021

Patent Application Number

20190325

Date Filed

March 25, 2019

Patent Citations Received

‌

US Patent 12071482 Compositions and methods related to engineered Fc constructs

‌

US Patent 11623964 Compositions and methods related to engineered Fc constructs

Patent abstract

The present invention relates to compositions and methods of engineered IgG Fc constructs, wherein said Fc constructs include one or more Fc domains.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11124573 Compositions and methods related to engineered Fc constructs

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API

By using this site, you agree to our Terms of Service.